Literature DB >> 11752149

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

A C M Boon1, G de Mutsert, Y M F Graus, R A M Fouchier, K Sintnicolaas, A D M E Osterhaus, G F Rimmelzwaan.   

Abstract

The repertoire of human cytotoxic T-lymphocytes (CTL) in response to influenza A viruses has been shown to be directed towards multiple epitopes, with a dominant response to the HLA-A2-restricted M1(58-66) epitope. These studies, however, were performed with peripheral blood mononuclear cells (PBMC) of individuals selected randomly with respect to HLA phenotype or selected for the expression of one HLA allele without considering an influence of other HLA molecules. In addition, little information is available on the influence of HLA makeup on the overall CTL response against influenza viruses. Here, the influenza A virus-specific CTL response was investigated in groups of HLA-A and -B identical individuals. Between groups the individuals shared two or three of the four HLA-A and -B alleles. After in vitro stimulation of PBMC with influenza virus, the highest CTL activity was found in HLA-A2(+) donors. A similar pattern was observed for the precursor frequency of virus-specific CTL (CTLp) ex vivo, with a higher CTLp frequency in HLA-A2-positive donors than in HLA-A2-negative donors, which were unable to recognize the immunodominant M1(58-66) epitope. In addition, CTL activity and frequency of CTLp for the individual influenza virus epitopes were determined. The frequency of CTLp specific for the HLA-B8-restricted epitope NP(380-388) was threefold lower in HLA-B27-positive donors than in HLA-B27-negative donors. In addition, the frequency of CTLp specific for the HLA-A1-restricted epitope NP(44-52) was threefold higher in HLA-A1-, -A2-, -B8-, and -B35-positive donors than in other donors, which was confirmed by measuring the CTL activity in vitro. These findings indicate that the epitope specificity of the CTL response is related to the phenotype of the other HLA molecules. Furthermore, the magnitude of the influenza virus-specific CTL response seems dependent on the HLA-A and -B phenotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752149      PMCID: PMC136822          DOI: 10.1128/jvi.76.2.582-590.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.

Authors:  G F Rimmelzwaan; N Nieuwkoop; A Brandenburg; G Sutter; W E Beyer; D Maher; J Bates; A D Osterhaus
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

2.  Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.

Authors:  A X Mo; S F van Lelyveld; A Craiu; K L Rock
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

3.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Authors:  O Mandelboim; N Lieberman; M Lev; L Paul; T I Arnon; Y Bushkin; D M Davis; J L Strominger; J W Yewdell; A Porgador
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

5.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

Authors:  P O Flores-Villanueva; E J Yunis; J C Delgado; E Vittinghoff; S Buchbinder; J Y Leung; A M Uglialoro; O P Clavijo; E S Rosenberg; S A Kalams; J D Braun; S L Boswell; B D Walker; A E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

6.  Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.

Authors:  G T Belz; W Xie; P C Doherty
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.

Authors:  K J Jeffery; A A Siddiqui; M Bunce; A L Lloyd; A M Vine; A D Witkover; S Izumo; K Usuku; K I Welsh; M Osame; C R Bangham
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

Authors:  W Chen; C C Norbury; Y Cho; J W Yewdell; J R Bennink
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.

Authors:  A E Lukacher; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  60 in total

1.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.

Authors:  Julia R Gog; Guus F Rimmelzwaan; Albert D M E Osterhaus; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

2.  Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host.

Authors:  Jennifer L Nayak; Andrea J Sant
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.

Authors:  Heather M Machkovech; Trevor Bedford; Marc A Suchard; Jesse D Bloom
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantage.

Authors:  Rick J Stoffels; Hamish G Spencer
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

5.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

6.  Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

Authors:  Carolien E van de Sandt; YingYing Dou; Stella E Vogelzang-van Trierum; Kim B Westgeest; Mark R Pronk; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan; Marine L B Hillaire
Journal:  J Gen Virol       Date:  2015-04-21       Impact factor: 3.891

7.  T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.

Authors:  Angela Wahl; William McCoy; Fredda Schafer; Wilfried Bardet; Rico Buchli; Daved H Fremont; William H Hildebrand
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  Immunodominant responses to the influenza virus M158-66 epitope: Stealth or protection?

Authors:  Carolien E van de Sandt; Guus F Rimmelzwaan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

9.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs.

Authors:  Heui Man Kim; Young-Won Lee; Ki-Ja Lee; Hyun Soo Kim; Sung Whan Cho; Nico van Rooijen; Yi Guan; Sang Heui Seo
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.